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Purpose: Globular adiponectin (gAd) is a type of adipocytokine, which is mainly produced by adipose tissue. It has been report­
ed that gAd acts as a pro­ as well as an anti­inflammatory factor. Interleukin (IL)­6 and IL­8 are pro­inflammatory cytokines. To 
investigate the role of gAd on periodontal tissues, the expression of adiponectin receptor 1 (AdipoR1) and the effect of gAd on 
the expression of IL­6 and IL­8 were investigated in periodontal ligament (PDL) and gingival fibroblasts. 
Methods: PDL and gingival fibroblasts were cultured from human periodontal tissues. gAd derived from Escherichia coli and 
murine myeloma cells were used. The expression of AdipoR1 was estimated by reverse transcription­polymerase chain reac­
tion and western blot. The expression of cytokines was measured by enzyme­linked immunosorbent assay. 
Results: PDL and gingival fibroblasts expressed both mRNA and protein of AdipoR1. gAd derived from E. coli increased the 
production of IL­6 and IL­8, but polymyxin B, an inhibitor of lipopolysaccharide (LPS), inhibited IL­6 and IL­8 production in­
duced by gAd in both types of cells. gAd derived from murine myeloma cells did not induce IL­6 and IL­8 production in those 
cells. gAd derived from E. coli contained higher levels of LPS than gAd derived from murine myeloma cells. LPS increased pro­
duction of IL­6 and IL­8 in PDL and gingival fibroblasts, but pretreatment of cells with gAd derived from murine myeloma 
cells did not inhibit LPS­induced IL­6 and IL­8 expression. 
Conclusions: Our results suggest that PDL and gingival fibroblasts express AdipoR1 and that gAd does not act as a modulator 
of IL­6 and IL­8 expression in PDL and gingival fibroblasts.
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INTRODUCTION 
Periodontitis is an inflammatory disease caused by bacteria 
and the inflammatory/immune response to bacteria. Epide­
miological studies have suggested that periodontitis is inti­
mately related with obesity [1­2] and diabetes [3]. Several stu­
dies have reported that adipocytokines, which are produced 
by adipocytes, can modulate inflammation [4] and insulin sen­
sitivity [5]. Therefore, the role of adipocytokines in the patho­
genesis of periodontitis has become an area of interest in re­
search. 
Adiponectin is a type of adipocytokine, produced mainly by 
adipose tissue [6,7]. Studies have shown that adiponectin is 
also expressed in skeletal muscle cells and cardiac and syno­
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vial fibroblasts [4,8,9]. There are two types of adiponectin: a 
full­length adiponectin (fAd) and a globular adiponectin (gAd) 
[6]. fAd consists of an N­terminal signal peptide, a variable 
domain, a collagen­like domain, and a C­terminal C1q­like 
globular domain [4]. gAd consists of a globular domain that 
is cleaved from fAd by proteolysis [7]. Two receptors for adi­
ponectin have been reported: adiponectin receptor 1 (Adi­
poR1) is a high affinity receptor for gAd, and AdipoR2 is an 
intermediate affinity receptor for gAd and fAd [10].
Until now, the role of adiponectin in inflammation has not 
been clear. Some studies have demonstrated that adiponec­
tin has a pro­inflammatory effect, but others showed an anti­
inflammatory effect or did not show any effects. The pro­in­
flammatory effects of adiponectin have been suggested by 
demonstrating its cytokine­induction activity. Research has 
shown that fAd stimulates the production of interleukin (IL)­
8 and monocyte chemoattractant protein­1 in monocytes 
and endothelial cells [11]. In addition, fAd has been shown to 
stimulate production of IL­6 and IL­8 by rheumatoid synovi­
al fibroblasts, suggesting that adiponectin is involved in the 
pathogenesis of rheumatoid arthritis [12,13]. Studies have also 
shown that gAd induces the production of IL­1β, IL­6, IL­8, 
and TNFα in macrophages [14,15] and IL­6 in cardiac fibro­
blasts [16]. However, other studies have demonstrated that 
adiponectin has an anti­inflammatory effect by showing its 
induction of tolerance to lipopolysaccharide (LPS) and inhi­
bition of phagocytosis in macrophages. Pretreatment with 
gAd reduced LPS­induced production of IL­6 and TNFα in 
macrophages, suggesting that adiponectin causes macro­
phages to become resistant to LPS [14]. Treatment of macro­
phages with adiponectin inhibited macrophage phagocyto­
sis, suggesting that adiponectin suppresses macrophage func­
tion and that inhibitionby adiponectin of macrophages may 
contribute to termination of the inflammatory reaction [17]. 
However, other studies have not been able to demonstrate 
the induction of IL­6 and TNFα and the suppression of LPS­
induced IL­6 and TNFα production by adiponectin in mac­
rophages, suggesting that some adiponectin effects, such as 
the inhibition and stimulation of cytokine (IL­6 and TNFα) 
production in macrophages, may be confused by LPS con­
tamination [18,19].
Interestingly, adiponectin plasma levels are high in healthy 
humans and decreased in individuals with obesity and type 2 
diabetes [20,21]. One study found a trend toward decreased 
serum levels of adiponectin in periodontitis patients [22]. More­
over, infection with periodontopathogen such as Porphyromo-
nas gingivalis was shown to cause decreased serum levels of 
adiponectin in type 2 diabetic mice [23]. In another study, an­
timicrobial periodontal treatment (APT) not only ameliorated 
periodontitis but also increased serum levels of adiponectin 
in type 2 diabetes mellitus patients. It has been proposed that 
amelioration of periodontitis by APT might cause an increase 
in serum levels of adiponectin in type 2 diabetic subjects [24]. 
Pretreatment of mice with gAd was shown to suppress Ag-
gregatibacter actinomycetemcomitans LPS­induced TNFα ex­
pression in a murine macrophage cell line [25]. gAd was also 
found to suppress osteoclast formation induced by LPS of A. 
actinomycetemcomitans [26]. Those reports suggest that, in 
periodontitis, adiponectin may function as an inhibitor of 
both LPS­mediated cytokine expression in macrophages and 
LPS­mediated osteoclast formation. Periodontal ligament 
(PDL) and gingival fibroblasts play an important role in the 
pathogenesis of periodontitis by producing pro­inflammato­
ry cytokines such as IL­6 and IL­8 [27]. To this date, however, 
the role of adiponectin in PDL and gingival fibroblasts has 
not been clearly determined. In this study, the expression of 
adiponectin AdipoR1 and the effect of gAd on the expression 
of IL­6 and IL­8 were investigated in PDL and gingival fibro­
blasts. 
MATERIALS AND METHODS
Culture of cells
Human PDL fibroblasts were prepared from extracted teeth 
for orthodontic treatment as described previously [28]. The 
protocol was approved by the Institutional Review Board of 
Yonsei Dental Hospital (IRB No. 2­2010­0005). Using blades, 
PDL tissue fragments were removed from the middle one 
third of the extracted tooth roots and washed three times 
with α­modified Eagle’s medium (α­MEM, Gibco BRL, San 
Diego, CA, USA) containing antibiotics of 300 mg/mL strep­
tomycin, 300 unit/mL penicillin, and 0.75 mg/mL amphoteri­
cin­B (Gibco BRL). PDL tissue fragments were placed in 100­
mm dishes containing α­MEM supplemented with the anti­
biotics of 100 mg/mL streptomycin, 100 unit/mL penicillin, 
0.25 mg/mL amphotericin­B, and 20% fetal bovine serum 
(FBS, Gibco BRL). The culture media was replaced every 2 days 
until cells grew from the fragments, after which the cultures 
were maintained with α­MEM containing antibiotics and 
10% FBS. Upon reaching 70% confluence, the cells were re­
moved with 0.25% trypsin and passaged to 100­mm dishes. 
Gingival fibroblasts were prepared from gingival tissues ex­
cised for crown lengthening. Gingival tissues were cut into 
small fragments, and then the tissue fragments were incu­
bated in 2.4 U dispase II (Roche, Mannheim, Germany) and 
0.25% collagenase (Roche) for 1 hour at 37°C. The tissue frag­
ments were then separated into epithelium and connective 
tissue. Connective tissue fragments were placed in 100­mm 
dishes containing Dulbecco’s modified Eagle’s medium (DM­
EM, Gibco BRL) supplemented with antibiotics and 10% FBS Journal of Periodontal
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and were cultured according to the same procedure as PDL 
fibroblasts. The cells used in this study had been passaged 5 
times. THP­1 monocytes and MDA­MB231 breast cancer cells 
were maintained in Roswell Park Memorial Institute 1640 
medium (Gibco BRL) and DMEM each containing both anti­
biotics and 10% FBS.
Western blotting
PDL fibroblasts, gingival fibroblasts or MDA­MB231 (5×10
5 
cells/well) were cultured in 6­well culture plates. THP­1 mono­
cytes (5×10
5 cells/well) were plated in 6­well plates and treat­
ed with phorbol 12­myristate 13­acetate (PMA, 100 ng/mL, 
Sigma­Aldrich Co., St. Louis, MO, USA) for 24 hours to induce 
the differentiation of monocytes into macrophages. After 
reaching confluence, the whole cells were lysed with lysis 
buffer (20 mM Tris­HCl, pH7.5, 150 mM NaCl, 1 mM Na2ED­
TA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM β­gly­
cerophosphate, 1 mM Na3VO4, 1 μg/mL leupeptin, and 1 mM 
phenylmethylsulfonyl fluoride; Cell Signaling Technology 
Inc., Danvers, MA, USA). After centrifugation at 12,000×g at 
4°C, the supernatant was used for the protein assay. Protein 
concentrations were determined with bovine serum albu­
min protein assay kits (Bio­Rad Laboratories Inc., Hercules, 
CA, USA). Forty micrograms of protein per sample of cell ex­
tract were run on a 10% SDS­polyacrylamide gel electropho­
resis and then electroblotted onto a polyvinylidene fluoride 
membrane (Bio­Rad Laboratories Inc.). The membranes were 
blocked with 5% skim milk in tris­buffered saline (10 mM 
Tris­HCl, 166 mM NaCl, pH 7.4) for 1 hr, rinsed, and then in­
cubated overnight with primary antibodies against adipo­
nectin (R&D Systems Inc., Minneapolis, MN, USA), AdipoR1 
(Abcam plc, Cambri  dge, UK), or actin (SantaCruz Biotechnol­
ogy, Santa Cruz, CA, USA) at a dilution of 1:1,000. Secondary 
antibody, peroxidase­conjugated anti­rabbit antibody (Jack­
son ImmunoResearch Laboratories Inc., West Grove, PA, 
USA), was used at 1:2,500. Protein bands were visualized by 
an ECL kit (Amersham, Buckinghamshire, UK). 
Reverse transcription-polymerase chain reaction (RT-PCR)
PDL fibroblasts or gingival fibroblasts (5×10
5 cells/well) were 
cultured in 6­well culture plates. THP­1 monocytes (5×10
5 
cells/well) were plated in 6­well plates and treated with PMA 
(100 ng/mL) for 24 hours to induce the differentiation of mo­
nocytes into macrophages. After reaching confluence, total 
RNA in PDL fibroblasts, gingival fibroblasts, or THP­1 mac­
rophages was isolated with Trizol reagent (Invitrogen, Carls­
bad, CA, USA). Two micrograms of total RNA was converted 
to cDNA using an RT premix kit (Bioneer, Seoul, Korea) in ac­
cordance with the manufacturer’s instructions. The cDNA 
was amplified with i­StarTaq (Intron Biotech, Seongnam, Ko­
rea). The primers used for RT­PCR were as follows: AdipoR1s­
ense primer, 5´­CCTTTCCCCAAGCTGAAGCTGC­3´ and an­
tisense primer, 5´­CCTTGACAAAGCCCTCAGCGAT­3´; GAP­
DH sense primer, 5´­CGGAGTCAACGGATTTGGTCGTAT­3´ 
and antisense primer, 5´­AGCCTTCTCCATGGTGGTGAAG­
AC­3´. For AdipoR1, the reaction mixtures were subjected to 
35 cycles of denaturation and annealing at 60°C. For GAPDH, 
the reaction mixtures were subjected to 28 cycles of denatur­
ation and annealing at 56°C. The PCR products were then re­
solved by electrophoresis in a 1% agarose gel containing eth­
idium bromide. 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium (MTT) 
assay
Cell viability was measured using an MTT assay. PDL fibro­
blasts or gingival fibroblasts (1.7×10
5 cells/well) were seeded 
in 24­well plates and maintained in media containing antibi­
otics and 10% FBS. After being maintained for 7 hours, the 
cells were starved in serum­free media for 20 hours and then 
treated with the indicated concentration of polymyxin B for 
24 hours. After treatment, 20 μL of MTT solution (5 mg/mL 
in PBS, Sigma­Aldrich Co.) was added to each well. After in­
cubation for 4 hours, the medium was aspirated, and 200 μL 
of dimethylsulfoxide was added to each well to dissolve 
MTT­formazan crystals. The plates were shaken for 5 min­
utes, and the absorbance was measured on an MRX II micro­
plate rea  der (Dynatech Laboratories Inc., Chantilly, VA, USA) 
at 570 nm. 
Enzyme-linked immunosorbent assay (ELISA)
PDL fibroblasts or gingival fibroblasts (1.7×10
5 cells/well) 
were plated in 24­well culture plates and maintained in me­
dia containing antibiotics and 10% FBS for 7 hours. THP­1 
monocytes were plated in 24­well plates and treated with PMA 
for 24 hours to induce the differentiation of monocytes into 
macrophages. After being maintained for the indicated time, 
the cells were starved in serum­free media for 20 hours and 
then treated with myeloma cell­derived recombinant gAd 
(M­gAd, R&D systems), Escherichia coli­derived gAd (E­gAd, 
Phoenix Pharmaceuticals, Burlingame, USA), or LPS (Sigma­
Aldrich Co.) for 24 hours. For polymyxin B treatment, cells 
were pretreated with polymyxin B for 1 hour and then treated 
with M­gAd, E­gAd, or LPS for 24 hours. For estimating the 
induction of tolerance to LPS by gAd, the cells were pretreat­
ed with gAd for 24 hours and then treated with LPS for an 
additional 24 hours. After the treatment, the levels of IL­6 or 
IL­8 were measured in the culture supernatants of PDL fi­
broblasts, gingival fibroblasts, or THP­1 macrophages using 
an ELISA kit (BioLegend, San Diego, CA, USA) in accordance 
with the manufacturer’s instructions.Journal of Periodontal
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Statistical analysis 
The results were analyzed using one­way analysis of vari­
ance and Tu  key’s test. A P­value of <0.05 was considered to 
indicate statistical significance. 
RESULTS
Expression of adiponectin and adiponectin receptor
Expression of adiponectin was estimated by western blot. 
Subcutaneous adipose tissue from the inguinal region ex­
pressed adiponectin, but PDL fibroblasts, gingival fibroblasts, 
and THP­1 macrophages did not show adiponectin expres­
sion (Fig. 1A). Expression of AdipoR1 was estimated by RT­PCR 
and western blot. Like THP­1 macrophages, which have been 
known to express AdipoR1, PDL and gingival fibroblasts ex­
pressed mRNA of AdipoR1 (Fig. 1B) [29]. Similar to THP­1 ma­
crophages and the breast cancer cell line MDA­MB231,which 
are positive controls for the expression of AdipoR1, PDL and 
gingival fibroblasts also expressed the protein of AdipoR1 
(Fig. 1C) [30]. 
Effect of gAd on expression of IL-6 and IL-8 in PDL cells 
and gingival fibroblasts 
The effect of gAd on the expression of IL­6 and IL­8 was 
estimated in PDL and gingival fibroblasts by ELISA. Treat­
ment with E. coli­derived gAd increased the expression of 
IL­6 and IL­8 in PDL fibroblasts, but treatment with myelo­
ma cell line­derived gAd did not increase the expression of 
IL­6 and IL­8 (Fig. 2A, B). Polymyxin B is an inhibitor of LPS. 
Polymyxin B blocked IL­6 and IL­8 expression induced by E. 
coli­derived gAd at a concentration of 100 μg/mL which poly­
myxin B inhibited LPS activity (Fig. 2A, B). Treatment of gin­
gival fibroblasts with E. coli­ or myeloma cell­derived gAd 
showed results similar to those of PDL fibroblasts (Fig. 3A, B). 
Polymyxin B did not have a cytotoxic effect on PDL and gin­
gival fibroblasts at concentrations less than or equal to 500 
μg/mL (Figs. 2C, 3C). LPS increased IL­6 and IL­8 expression 
in THP­1 macrophages, but myeloma cell­derived gAd did 
not stimulate expression of those cytokines (Fig. 4).
Effect of gAd on LPS-induced IL-6 and IL-8 expression 
To estimate the induction of tolerance to LPS by gAd, PDL 
and gingival fibroblasts were pretreated with myeloma cell­
derived gAd before exposure to LPS. LPS increased the ex­
pression of IL­6 and IL­8 in PDL fibroblasts, but pretreatment 
of cells with gAd did not decrease or increase the expression 
of IL­6 and IL­8 induced by LPS (Fig. 5A). Gingival fibroblasts 
showed results similar to those of PDL fibroblasts (Fig. 5B). 
DISCUSSION
The alteration in serum levels of adiponectin according to 
periodontal status and the effect of adiponectin on periodon­
topathogen­induced cytokine expression by macrophages 
and osteoclast formation have been estimated [23­25], but 
few studies have addressed the effect of adiponectin on the 
cells of periodontal tissue such as PDL and gingival fibro­
blasts. In this study, it was shown that PDL and gingival fi­
broblasts express AdipoR1 and that gAd does not affect the 
production of IL­6 and IL­8 in those cells.
Although the main source of adiponectin is adipocytes, sy­
novial and cardiac fibroblasts also express adiponectin [4,8,31]. 
In this study, we also found expression of adiponectin in adi­
pocytes, but PDL and gingival fibroblasts did not express adi­
ponectin like synovial and cardiac fibroblasts. AdipoR1 is most 
highly expressed in skeletal muscle [4], but its expression has 
also been detected in synovial and cardiac fibroblasts [8,12,13]. 
As a result, we looked for the expression of AdipoR1 in PDL 
and gingival fibroblasts. Similar to synovial and cardiac fi­
broblasts, PDL and gingival fibroblasts expressed not only 
the mRNA but also the protein of AdipoR1. 
Adipose 
tissue PDL
Ad
Actin
GF THP-1
PDL
AdipoR1
GAPDH
GF THP-1
MDA PDL GF THP-1
AdipoR1
Actin
A
B
C
Figure 1. Expression of adiponectin and adiponectin receptor 1 in 
periodontal ligament and gingival fibroblasts. Expression of adipo­
nectin (Ad) in adipose tissue, periodontal ligament (PDL) fibroblasts, 
gingival fibroblasts (GF), and THP­1 macrophages was estimated by 
western blot (A). Expression of adiponectin receptor 1 (AdipoR1) in 
PDL fibroblasts, GF, MDA­MB231 breast cancer cell line (MDA), and 
THP­1 macrophages was estimated by reverse transcription­poly­
merase chain reaction (B) and western blot (C).Journal of Periodontal
& Implant Science JPIS
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IL­6 induces the differentiation of B cells to antibody­se­
creting plasma cells and stimulates bone resorption [32,33]. 
IL­8 stimulates the attraction and activation of neutrophils 
and bone resorption [32]. The IL­6 and IL­8 levels of periodon­
titis patients are higher than those of healthy patients [32]. 
That evidence suggests that IL­6 and IL­8 play an important 
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Figure 2. Effect of globular adiponectin on the expression of inter­
leukin (IL)­6 and IL­8 in periodontal ligament fibroblasts. Periodon­
tal ligament fibroblasts were treated with murine myeloma cell­de­
rived globular adiponectin (M­gAd, 15 μg/mL), Escherichia coli­de­
rived gAd (E­gAd, 15 μg/mL), or lipopolysaccharide (LPS) (100 ng/
mL) in the presence or absence of polymyxin B (100 μg/mL) for 24 
hours. Levels of IL­6 (A) and IL­8 (B) in culture supernatants were 
assayed by enzyme­linked immunosorbent assay. Cell viability treat­
ed with polymyxin B was estimated by an 3­(4,5­dimethylthiazol­2­
yl)­2,5­diphenyltetrazolium assay (C). 
a)Significantly different from 
untreated cells (P<0.05).  
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Figure 3. Effect of globular adiponectin on the expression of inter­
leukin (IL)­6 and IL­8 in gingival fibroblasts. Gingival fibroblasts 
were treated with murine myeloma cell­derived globular adiponec­
tin (M­gAd, 15 μg/mL), Escherichia coli­derived gAd (E­gAd, 15 μg/
mL), or lipopolysaccharide (LPS) (100 ng/mL) in the presence or ab­
sence of polymyxin B (100 μg/mL) for 24 hours. Levels of IL­6 (A) 
and IL­8 (B) in culture supernatants were assayed by enzyme­linked 
immunosorbent assay. The effect of gAd on the expression of cyto­
kines was compared with LPS. Cell viability treated with polymyxin 
B was estimated by an 3­(4,5­dimethylthiazol­2­yl)­2,5­diphenyltet­
razolium assay (C). 
a)Significantly different from untreated cells (P< 
0.05).  
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role in the pathogenesis of periodontitis. In this study, PDL 
and gingival fibroblasts expressed AdipoR1, which is a recep­
tor for gAd [10]. The serum level of adiponectin was found to 
be 12.4±5.1 μg/mL in humans with healthy gingival [34]. As a 
result, we investigated the effect of gAd on IL­6 and IL­8 ex­
pression of those cells at a concentration of 15 μg/mL. Sourc­
es of commercially available recombinant gAd are E. coli and 
murine myeloma cells. Therefore, we investigated the effect 
of E. coli­ and murine myeloma cell­derived gAd on the ex­
pression of those cytokines. E. coli­derived gAd increased 
IL­6 and IL­8 production in PDL and gingival fibroblasts. How­
ever, polymyxin B, an inhibitor of LPS, blocked not only the 
production of IL­6 and IL­8 induced by LPS, but also the pro­
duction of those cytokines induced by E. coli­derived gAd. 
Analysis of E. coli­derived gAd by a limulus amebocyte lysate 
assay revealed contamination with LPS (data not shown). That 
suggests that the effect of E. coli­derived gAd is due to con­
taminated LPS. Murine myeloma cell­derived gAd contained 
lower levels of LPS than E. coli­derived gAd (data not shown). 
To confirm the effect of gAd, the effect of murine myeloma 
cell­derived gAd was estimated. Murine myeloma cell­de­
rived gAd did not show an increase of IL­6 and IL­8 produc­
Figure 4. Effect of globular adiponectin on the production of interleukin (IL)­6 and IL­8 in THP­1 macrophages. THP­1 macrophages were 
cultured for 24 hours in the presence of murine myeloma cell­derived globular adiponectin (M­gAd) or lipopolysaccharide (LPS). The levels 
of IL­6 (A) and IL­8 (B) in culture supernatants were assayed by enzyme­linked immunosorbent. 
a)Significantly different from untreated cells 
(P<0.05).
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Figure 5. Effect of globular adiponectin on the production of interleukin (IL)­6 and IL­8 induced by lipopolysaccharide (LPS) in periodontal 
ligament and gingival fibroblasts. Periodontal ligament fibroblasts (A) and gingival fibroblasts (B) were cultured for 24 hours in the presence 
of murine myeloma cell­derived globular adiponectin (M­gAd, 15 μg/mL) and then stimulated for 24 hours with LPS (100 ng/mL). The levels 
of IL­6 and IL­8 in the culture supernatant were assayed by enzyme­linked immunosorbent. 
a)Significantly different from untreated cells 
(P<0.05). 
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tion in PDL or gingival fibroblasts. Those results indicate that 
gAd does not affect IL­6 and IL­8 production in PDL and gin­
gival fibroblasts.
gAd induced IL­6 and IL­8 secretion by THP­1 macropha­
ges [14,15]. However, in this study, gAd derived from murine 
myeloma cells did not stimulate those cytokines in the same 
cell lines. Similar to our results, the outcome of one study 
showed that fAd­induced IL­6 production was blocked by 
polymyxin B in macrophages, suggesting that fAd does not 
induce IL­6 induction and that evaluation of certain effects 
of adiponectin may be entangled by LPS contamination [19]. 
Our results also support the proposal that LPS contamination 
be considered when estimating the function of adiponectin 
in inflammation. 
It has been reported that pretreatment of macrophages with 
adiponectin induces tolerance to LPS, suggesting that adipo­
nectin has anti­inflammatory properties [14]. However, in 
another study, the tolerance effect of adiponectin on LPS­in­
duced cytokine expression was not found [18]. Our results 
showed that pretreatment of PDL and gingival fibroblasts 
with murine myeloma cell­derived gAd did not decrease LPS­ 
induced IL­6 and IL­8 expression, suggesting that gAd does 
not induce tolerance to LPS in PDL and gingival fibroblasts. 
Previous reports have shown that adiponectin stimulates 
the production of IL­6 and IL­8 by rheumatoid synovial fi­
broblasts, indicating that the pro­inflammatory effects of ad­
iponectin might play a role in the pathogenesis of rheuma­
toid arthritis [9,12,13]. In this study, however, we could not 
find the pro­inflammatory effect of adiponectin in PDL and 
gingival fibroblasts in periodontal tissue. Recently, Yamagu­
chi et al. [35] reported expression of AdipoR1 in gingival fibro­
blasts, but they did not estimate either the expression of Adi­
poR1 in PDL cells or the effect of adiponectin on the expres­
sion of cytokines in those cells. This study is meaningful in 
its demonstration of the expression of AdipoR1 in both PDL 
and gingival fibroblasts, its estimation of the effect of gAd on 
IL­6 and IL­8 expression, and its suggestion of the signifi­
cance of LPS contamination in estimating the function of 
gAd. 
In conclusion, our results showed that PDL and gingival fi­
broblasts expressed AdipoR1, and gAd did not affect the ex­
pression of IL­6 and IL­8 in those cells. Although gAd did not 
have a modulating effect on IL­6 and IL­8 expression in those 
cells, expression of AdipoR1 indicates that gAd may have oth­
er effects on PDL and gingival fibroblasts, which will be stud­
ied in the future. 
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